Krystal Biotech (KRYS) Competitors $194.70 +1.72 (+0.89%) As of 09:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KRYS vs. SMMT, ASND, VTRS, RDY, MRNA, ROIV, QGEN, ELAN, BBIO, and VRNAShould you be buying Krystal Biotech stock or one of its competitors? The main competitors of Krystal Biotech include Summit Therapeutics (SMMT), Ascendis Pharma A/S (ASND), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Moderna (MRNA), Roivant Sciences (ROIV), QIAGEN (QGEN), Elanco Animal Health (ELAN), BridgeBio Pharma (BBIO), and Verona Pharma PLC American Depositary Share (VRNA). These companies are all part of the "pharmaceutical products" industry. Krystal Biotech vs. Its Competitors Summit Therapeutics Ascendis Pharma A/S Viatris Dr. Reddy's Laboratories Moderna Roivant Sciences QIAGEN Elanco Animal Health BridgeBio Pharma Verona Pharma PLC American Depositary Share Krystal Biotech (NASDAQ:KRYS) and Summit Therapeutics (NASDAQ:SMMT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings. Which has stronger earnings & valuation, KRYS or SMMT? Krystal Biotech has higher revenue and earnings than Summit Therapeutics. Summit Therapeutics is trading at a lower price-to-earnings ratio than Krystal Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKrystal Biotech$359.21M15.69$89.16M$4.9239.57Summit Therapeutics$700K24,717.80-$221.32M-$1.01-23.06 Is KRYS or SMMT more profitable? Krystal Biotech has a net margin of 40.85% compared to Summit Therapeutics' net margin of 0.00%. Krystal Biotech's return on equity of 15.21% beat Summit Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Krystal Biotech40.85% 15.21% 13.81% Summit Therapeutics N/A -208.64%-181.28% Does the media favor KRYS or SMMT? In the previous week, Summit Therapeutics had 1 more articles in the media than Krystal Biotech. MarketBeat recorded 8 mentions for Summit Therapeutics and 7 mentions for Krystal Biotech. Summit Therapeutics' average media sentiment score of 0.78 beat Krystal Biotech's score of 0.39 indicating that Summit Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Krystal Biotech 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Summit Therapeutics 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in KRYS or SMMT? 86.3% of Krystal Biotech shares are owned by institutional investors. Comparatively, 4.6% of Summit Therapeutics shares are owned by institutional investors. 13.7% of Krystal Biotech shares are owned by insiders. Comparatively, 84.9% of Summit Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, KRYS or SMMT? Krystal Biotech has a beta of 0.64, indicating that its share price is 36% less volatile than the S&P 500. Comparatively, Summit Therapeutics has a beta of -1.13, indicating that its share price is 213% less volatile than the S&P 500. Do analysts recommend KRYS or SMMT? Krystal Biotech presently has a consensus target price of $209.00, indicating a potential upside of 7.34%. Summit Therapeutics has a consensus target price of $31.29, indicating a potential upside of 34.32%. Given Summit Therapeutics' higher probable upside, analysts clearly believe Summit Therapeutics is more favorable than Krystal Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Krystal Biotech 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Summit Therapeutics 4 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.50 SummaryKrystal Biotech beats Summit Therapeutics on 10 of the 17 factors compared between the two stocks. Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KRYS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRYS vs. The Competition Export to ExcelMetricKrystal BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.64B$3.37B$6.12B$10.45BDividend YieldN/A2.30%5.73%4.78%P/E Ratio39.5822.7785.3227.36Price / Sales15.69486.78603.66198.22Price / Cash40.5546.7037.4661.86Price / Book5.9210.5512.566.81Net Income$89.16M-$52.58M$3.32B$276.80M7 Day Performance3.15%0.09%0.63%0.42%1 Month Performance26.12%15.61%10.55%7.86%1 Year Performance9.52%15.13%75.10%41.24% Krystal Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRYSKrystal Biotech4.3787 of 5 stars$194.71+0.9%$209.00+7.3%+8.1%$5.64B$359.21M39.58210Analyst RevisionSMMTSummit Therapeutics2.8544 of 5 stars$22.15+3.4%$31.29+41.2%+3.7%$15.92B$700K-21.93110Analyst UpgradeASNDAscendis Pharma A/S3.2124 of 5 stars$210.83+3.3%$244.36+15.9%+62.7%$12.59B$393.54M-40.861,017News CoverageAnalyst ForecastAnalyst RevisionHigh Trading VolumeVTRSViatris2.3253 of 5 stars$10.13-0.6%$10.40+2.7%-15.7%$11.88B$14.74B-3.4932,000News CoverageAnalyst ForecastRDYDr. Reddy's Laboratories2.908 of 5 stars$14.12-0.3%$16.95+20.0%-11.0%$11.82B$3.81B21.3927,811News CoveragePositive NewsMRNAModerna4.2635 of 5 stars$27.54-3.3%$41.81+51.8%-51.6%$11.08B$3.24B-3.665,800ROIVRoivant Sciences3.0723 of 5 stars$16.26+0.6%$19.94+22.6%+43.0%$11.04B$29.05M-23.23860Insider TradeQGENQIAGEN4.2983 of 5 stars$46.99+0.4%$49.40+5.1%+11.5%$10.40B$1.98B27.765,765ELANElanco Animal Health2.6612 of 5 stars$20.68+0.2%$18.33-11.3%+47.1%$10.25B$4.44B24.059,000Analyst RevisionBBIOBridgeBio Pharma4.2233 of 5 stars$54.61+3.3%$63.94+17.1%+123.1%$10.11B$221.90M-13.35400Analyst RevisionVRNAVerona Pharma PLC American Depositary Share1.4602 of 5 stars$106.91+0.1%$109.00+2.0%N/A$9.20B$42.28M-107.9930Positive News Related Companies and Tools Related Companies SMMT Alternatives ASND Alternatives VTRS Alternatives RDY Alternatives MRNA Alternatives ROIV Alternatives QGEN Alternatives ELAN Alternatives BBIO Alternatives VRNA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRYS) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
